Amphastar Pharmaceuticals Inc (AMPH)
Cost of Revenue
$381.91M
TTM · Period ending: · USD
AMPH Cost of Revenue
Latest reported$381.91Mperiod ending
Latest reported$381.91Mperiod ending
AMPH Cost of Revenue ($90.25M → $381.91M)
Annual cost of revenue
High-resolution chart · PNG
AMPH cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 363,830,000 | |
| 358,112,000 | |
| 293,274,000 | |
| 250,127,000 | |
| 238,029,000 | |
| 206,506,000 | |
| 190,434,000 | |
| 187,681,000 | |
| 149,380,000 | |
| 150,976,000 | |
| 174,172,000 | |
| 159,205,000 | |
| 142,725,000 | |
| 114,020,000 | |
| 90,252,000 |